Certified by Founder Lodge
Andera Partners
France - Paris, Île-de-France
INVESTOR
1 Disclosed Funding Rounds $60,000,000
6 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Created over 20 years ago, Andera Partners is a major player in private company investments in France and internationally. Its teams manage over €3.6 billion in investments in life sciences (
| Company | Date | Round | Raised |
|---|---|---|---|
 SoniVie Ltd |
January, 17 ,2023 | Series C | $60,000,000 |
 BioVentrix |
April, 14 ,2023 | Series A | $48,500,000 |
 Ariceum Therapeutics |
April, 19 ,2023 | Series A | $27,393,000 |
 Evommune |
April, 27 ,2023 | Series B | $50,000,000 |
 mylight150 |
December, 05 ,2023 | Unknown | $108,326,000 |
 Grey Wolf Therapeutics |
May, 23 ,2024 | Series B | $50,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Rapafusyn Pharmaceuticals | $28,000,000 | (Jun 25, 2024)
Upword | $3,000,000 | (Jun 25, 2024)
Daydream | $50,000,000 | (Jun 25, 2024)
BillionToOne | $130,000,000 | (Jun 25, 2024)
Wilya | $4,000,000 | (Jun 25, 2024)
